Molecular Docking Studies on Isocytosine Analogues as Xanthine Oxidase Inhibitors

Abstract

Flexible docking simulations were carried out on a series of isocytosine analogs as xanthine oxidase (XO) inhibitors. This was done by analysing the interaction of these compounds at the active site of XO. The binding free energies of the analogs were calculated using GoldScore. The binding modes of the best-fit conformation were studied, providing some handy important interactions. The results obtained henceforth provided an insight into the pharmacophoric structural requirements for XO inhibition for this class of molecules.

Key words

Xanthine oxidase - isocytosine analogs - docking - gout - hyperuricemia

• References

• 1 Meng X-Y, Zhang H-X, Mezei M. et al. Molecular docking: A powerful approach for structure-based drug discovery. Curr Comput-Aid Drug 2011; 7: 146-157
• 2 Scholz C, Knorr S, Hamacher K. et al. Highly Versatile step-by-step workflow for covalent docking and virtual screening in the molecular operating environment. J Chem Inf Model 2015; 55: 398-406
• 3 Ferreira LG, dos Santos RN, Oliva G. et al. Molecular docking and structure-based drug design strategies. Molecules 2015; 20: 13384-13421
• 4 Bajaj K, Burudkar S, Shah P. et al. Lead optimization of isocytosine-derived xanthine oxidase inhibitors. Bioorg Med Chem Lett 2013; 23: 834-838
• 5 Enroth C, Eger BT, Okamoto K. et al. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion. Proc Natl Acad Sci U.S.A. 2000; 97: 10723-10728
• 6 Ishikita H, Eger BT, Okamoto K. et al. Protein conformational gating of enzymatic activity in xanthine oxidoreductase. J Amer Chem Soc 2011; 134: 999-1009
• 7 Hille R, Nishino T. Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J 1995; 9: 995-1003
• 8 Nepali K, Singh G, Turan A. et al. A rational approach for the design and synthesis of 1-acetyl-35-diaryl-45-dihydro(1 H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors. Bioorg Med Chem 2011; 19: 1950-1958
• 9 Khanna S, Burudkar S, Bajaj K. et al. Isocytosine-based inhibitors of xanthine oxidase: Design synthesis SAR PK and in vivo efficacy in rat model of hyperuricemia. Bioorg Med Chem Lett 2012; 22: 7543-7546
• 10 Rao CB, Almeida AK, Katkar KV. et al. Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits. Bioorg Med Chem 2012; 20: 2930-2939
• 11 MOE The Molecular Operating Environment from Chemical Computing Group Inc.. 1255 University Street, Suite 1600. Montreal, Quebec, Canada: 2011. H3B 3×3 http://www.chemcomp.com